Financhill
Back

Merus NV Quote, Financials, Valuation and Earnings

Merus NV Price Quote

$41.84
-0.03 (-0.59%)
(Updated: December 21, 2024 at 5:37 AM ET)

Merus NV Key Stats

Sell
25
Merus NV (MRUS) is a Sell

Day range:
$41.59 - $43.26
52-week range:
$26.69 - $61.61
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
71.67
P/B ratio:
4.08%

Volume:
831.8K
Avg. volume:
635.5K
1-year change:
61.79%
Market cap:
$2.9B
Revenue:
$43.9M
EPS:
$-3.95

How Much Does Merus NV Make?

Data Unavailable

Is Merus NV Growing As A Company?

Data Unavailable

Merus NV Stock Price Performance

  • Did Merus NV Stock Go Up Last Month?
    Merus NV share price went down by -2.47% last month
  • Did MRUS's Share Price Rise Over The Last Year?
    MRUS share price rose by 61.79% over the past 1 year

What Is Merus NV 52-Week High & Low?

  • What Is Merus NV’s 52-Week High Share Price?
    Merus NV has traded as high as $61.61 over the past 52 weeks
  • What Is Merus NV’s 52-Week Low Share Price?
    Merus NV has traded as low as $26.69 over the past 52 weeks

Merus NV Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Merus NV?

Data Unavailable

Is Merus NV Cash Flow Positive?

Data Unavailable

Merus NV Return On Invested Capital

Data Unavailable

Merus NV Earnings Date & Stock Price

  • What Is Merus NV's Stock Price Today?
    A single share of MRUS can be purchased today for 41.87
  • What Is Merus NV’s Stock Symbol?
    Merus NV trades on the nasdaq under the ticker symbol: MRUS
  • When Is Merus NV’s Next Earnings Date?
    The next quarterly earnings date for Merus NV is scheduled on February 28, 2025
  • When Is MRUS's next ex-dividend date?
    Merus NV's next ex-dividend date is December 22, 2024
  • How To Buy Merus NV Stock?
    You can buy Merus NV shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Merus NV Competitors

  • Who Are Merus NV's Competitors?
    Below is a list of companies who compete with Merus NV or are related in some way:
    • argenx SE (ARGX)
    • Pharming Group (PHAR)
    • ProQR Therapeutics NV (PRQR)
    • Qiagen NV (QGEN)
    • uniQure NV (QURE)

Merus NV Dividend Yield

Data Unavailable

Merus NV Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -72.22%
Revenue: 6.7% 35.31%

Analyst Recommendations

Buy Recommendations: 12
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 86.07
Upside from Last Price: 105.57%

Major Shareholders

Data Unavailable